Related Experiment Video
Updated: Jun 26, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Initial growth deceleration during GnRH analogue therapy for precocious puberty
Frances Mouat1, Paul L Hofman, Craig Jefferies
1The Liggins Institute, University of Auckland, Auckland, New Zealand.
Goserelin showed greater initial growth suppression than leuprolide in children with precocious puberty. Relative tall stature influenced treatment response, with both gonadotropin-releasing hormone (GnRH) analogues effectively suppressing puberty biochemically.
Area of Science:
- Pediatric Endocrinology
- Reproductive Medicine
Background:
- Precocious puberty requires treatment to prevent adverse outcomes.
- Gonadotropin-releasing hormone (GnRH) analogues are standard treatment.
- Goserelin and leuprolide are commonly used GnRH analogues with varying efficacy.
Purpose of the Study:
- To compare goserelin and leuprolide efficacy in decelerating growth and weight gain.
- To assess the impact of initial treatment response over 12 months.
- To identify factors influencing treatment effectiveness in precocious puberty.
Main Methods:
- Retrospective cohort analysis of 40 children with precocious puberty.
- Comparison of goserelin versus leuprolide treatment groups.
- Primary outcomes: change in height SDS and BMI SDS over 12 months.
Main Results:
- Both GnRH analogues achieved similar luteinizing hormone (LH) suppression.
- Goserelin demonstrated significantly greater growth suppression in the first 6 months (P=0.025).
- Relative tall stature, advanced bone age, and BMI SDS predicted initial growth response.
Conclusions:
- Goserelin and leuprolide effectively suppress puberty biochemically.
- Goserelin offers superior initial linear growth deceleration in the first 6 months.
- Relative tall stature is a key factor in predicting treatment response.
Related Concept Videos
Signs of Puberty
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
GPCRs Regulate Adenylyl Cylase Activity
Two...
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

